OBJECTIVES: To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure. BACKGROUND: Natriuretic peptides such as NT-proBNP are important biomarkers in heart failure. The relationship between NT-proBNP and exercise capacity has not been well studied. METHODS: We analyzed the relationship between baseline NT-proBNP and peak oxygen uptake (peak VO(2)) or distance in the 6-minute walk test in 1383 subjects enrolled in the HF-ACTION study. Linear regression models were used to analyze the relationship between NT-proBNP and peak Vo(2) or distance in the 6-minute walk test in the context of other clinical variables. Receiver operator curve analysis was used to evaluate the ability of NT-proBNP to accurately predict a peak VO(2) <12 mL/kg per minute. RESULTS: NT-proBNP was the most powerful predictor of peak VO(2) (partial R(2) = 0.13, P < .0001) of 35 candidate variables. Although NT-proBNP was also a predictor of distance in the 6-minute walk test, this relationship was weaker than that for peak VO(2) (partial R(2) = 0.02, P < .0001). For both peak VO(2) and distance in the 6-minute walk test, much of the variability in exercise capacity remained unexplained by the variables tested. Receiver operator curve analysis suggested NT-proBNP had moderate ability to identify patients with peak VO(2) <12 mL/kg per minute (c-index, 0.69). CONCLUSIONS: In this analysis of baseline data from HF-ACTION, NT-proBNP was the strongest predictor of peak VO(2) and a significant predictor of distance in the 6-minute walk test. Despite these associations, NT-proBNP demonstrated only modest performance in identifying patients with a low peak VO(2) who might be considered for cardiac transplantation. These data suggest that, although hemodynamic factors are important determinants of exercise capacity, much of the variability in exercise performance in heart failure remains unexplained by traditional clinical and demographic variables.
RCT Entities:
OBJECTIVES: To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure. BACKGROUND: Natriuretic peptides such as NT-proBNP are important biomarkers in heart failure. The relationship between NT-proBNP and exercise capacity has not been well studied. METHODS: We analyzed the relationship between baseline NT-proBNP and peak oxygen uptake (peak VO(2)) or distance in the 6-minute walk test in 1383 subjects enrolled in the HF-ACTION study. Linear regression models were used to analyze the relationship between NT-proBNP and peak Vo(2) or distance in the 6-minute walk test in the context of other clinical variables. Receiver operator curve analysis was used to evaluate the ability of NT-proBNP to accurately predict a peak VO(2) <12 mL/kg per minute. RESULTS:NT-proBNP was the most powerful predictor of peak VO(2) (partial R(2) = 0.13, P < .0001) of 35 candidate variables. Although NT-proBNP was also a predictor of distance in the 6-minute walk test, this relationship was weaker than that for peak VO(2) (partial R(2) = 0.02, P < .0001). For both peak VO(2) and distance in the 6-minute walk test, much of the variability in exercise capacity remained unexplained by the variables tested. Receiver operator curve analysis suggested NT-proBNP had moderate ability to identify patients with peak VO(2) <12 mL/kg per minute (c-index, 0.69). CONCLUSIONS: In this analysis of baseline data from HF-ACTION, NT-proBNP was the strongest predictor of peak VO(2) and a significant predictor of distance in the 6-minute walk test. Despite these associations, NT-proBNP demonstrated only modest performance in identifying patients with a low peak VO(2) who might be considered for cardiac transplantation. These data suggest that, although hemodynamic factors are important determinants of exercise capacity, much of the variability in exercise performance in heart failure remains unexplained by traditional clinical and demographic variables.
Authors: Mandeep R Mehra; Jon Kobashigawa; Randall Starling; Stuart Russell; Patricia A Uber; Jayan Parameshwar; Paul Mohacsi; Sharon Augustine; Keith Aaronson; Mark Barr Journal: J Heart Lung Transplant Date: 2006-09 Impact factor: 10.247
Authors: Brian D Duscha; Brian H Annex; Howard J Green; Anne M Pippen; William E Kraus Journal: J Am Coll Cardiol Date: 2002-04-03 Impact factor: 24.094
Authors: P Jourdain; F Funck; M Bellorini; N Guillard; J Loiret; B Thebault; M Desnos; D Duboc Journal: Eur J Heart Fail Date: 2003-03 Impact factor: 15.534
Authors: Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett Journal: J Am Coll Cardiol Date: 2002-09-04 Impact factor: 24.094
Authors: Stefan Krüger; Jürgen Graf; Dagmar Kunz; Tina Stickel; Peter Hanrath; Uwe Janssens Journal: J Am Coll Cardiol Date: 2002-08-21 Impact factor: 24.094
Authors: Stefan Krüger; Jürgen Graf; Marc W Merx; Tina Stickel; Dagmar Kunz; Peter Hanrath; Uwe Janssens Journal: Int J Cardiol Date: 2004-05 Impact factor: 4.164
Authors: Robert J Mentz; Michael A Babyak; Vera Bittner; Jerome L Fleg; Steven J Keteyian; Ann M Swank; Ileana L Piña; William E Kraus; David J Whellan; Christopher M O'Connor; James A Blumenthal Journal: Circ Heart Fail Date: 2015-04-21 Impact factor: 8.790
Authors: Debra K Moser; Victoria Dickson; Tiny Jaarsma; Christopher Lee; Anna Stromberg; Barbara Riegel Journal: Curr Cardiol Rep Date: 2012-06 Impact factor: 2.931
Authors: G Michael Felker; Kevin J Anstrom; Kirkwood F Adams; Justin A Ezekowitz; Mona Fiuzat; Nancy Houston-Miller; James L Januzzi; Daniel B Mark; Ileana L Piña; Gayle Passmore; David J Whellan; Hongqiu Yang; Lawton S Cooper; Eric S Leifer; Patrice Desvigne-Nickens; Christopher M O'Connor Journal: JAMA Date: 2017-08-22 Impact factor: 56.272
Authors: Milos Parovic; Nduka C Okwose; Kristian Bailey; Lazar Velicki; Zlatko Fras; Petar M Seferovic; Guy A MacGowan; Djordje G Jakovljevic Journal: ESC Heart Fail Date: 2019-02-20